8468
J. Majer et al. / Tetrahedron 69 (2013) 8463e8469
trans/cis-7a with 85% yield after two steps (131 mg of the first-
eluted trans-7a and 111 mg of second-eluted cis-7a).
hexane/AcOEt compared to trans-7b; [
a
]
20 þ30.5 (c 1.20, CHCl3); IR
D
(film) 3553, 2957, 1723, 1602, 1452, 1316, 1178, 1151, 1113, 1071,
926 cmꢀ1 1H NMR (500 MHz, CDCl3)
; d 8.05e7.98 (m, 2H),
4.2.7.1. (2S,5S)-5-Allyl-5-hydroxy-2-(trityloxymethyl)-tetrahy-
7.62e7.54 (m, 1H), 7.49e7.41 (m, 2H), 5.84e5.72 (m, 1H), 5.23e5.13
(m, 2H), 4.54 (dd, J¼11.9, 6.3 Hz, 1H), 4.47e4.40 (m, 1H), 4.38 (dd,
J¼11.9, 3.6 Hz, 1H), 3.94 (d, J¼12.0 Hz, 1H), 3.78 (d, J¼12.0 Hz, 1H),
3.46 (s, 1H), 2.87e2.74 (m, 2H), 2.70 (dd, J¼14.3, 7.2 Hz, 1H), 2.45
20
dropyran-4-one (trans-7a). [
a
]
ꢀ60.1 (c 1.17, CHCl3); IR (film)
D
3495, 2926, 2875, 1717, 1491, 1449, 1220, 1146, 1079, 1054,
926 cmꢀ1; 1H NMR (500 MHz, CDCl3)
d
7.44e7.37 (m, 5H), 7.36e7.18
(m, 10H), 5.84e5.69 (m, 1H), 5.19e5.10 (m, 2H), 4.21e4.12 (m, 1H),
3.84 (d, J¼11.8 Hz, 1H), 3.70 (d, J¼11.8 Hz, 1H), 3.44 (s, 1H),
3.29e3.19 (m, 2H), 2.76e2.61 (m, 3H), 2.43 (dd, J¼14.3, 7.3 Hz, 1H);
(dd, J¼14.3, 7.4 Hz, 1H); 13C NMR (126 MHz, CDCl3)
d 207.0 (C), 166.1
(C), 133.3 (CH), 131.2 (CH), 129.7 (CH), 129.4 (C), 128.5 (CH), 119.7
(CH2), 76.7 (C), 74.9 (CH), 72.9 (CH2), 65.4 (CH2), 40.2 (CH2), 39.1
(CH2); HRMS calcd for C16H18O5Na [(MþNa)þ]: 313.1047; found:
313.1050.
13C NMR (126 MHz, CDCl3)
d 207.7 (C), 143.4 (C), 131.5 (CH), 128.6
(CH), 127.9 (CH), 127.2 (CH), 119.4 (CH2), 87.2 (C), 76.7 (C), 76.3 (CH),
73.0 (CH2), 64.9 (CH2), 40.7 (CH2), 39.2 (CH2); HRMS calcd for
C
28H28O4Na [(MþNa)þ]: 451.1880; found: 451.1902; HPLC: 98.0% ee
4.2.9. WackereTsuji oxidation: (2S,5S)-5-hydroxy-5-(2-oxopropyl)-
2-(trityloxymethyl)-tetrahydropyran-4-one (trans-8a). A 25-mL
round-bottomed flask was charged with (2S,5S)-trans-7a (122 mg,
0.284 mmol), PdCl2 (5.1 mg, 0.029 mmol), CuCl (29 mg, 0.29 mmol)
in a 7:1 mixture of DMF (5 mL) and H2O (0.72 mL). The resulting
dark-brown solution was stirred at room temperature under an
oxygen atmosphere (1 atm). After 12 h, an aqueous solution of
NaHCO3 (5%, 5 mL) was added and extracted with Et2O (10 mL) and
next with AcOEt (2ꢂ10 mL). The combined organic phases were
dried over Na2SO4, filtered, concentrated in vacuo, and purified by
column chromatography using hexane/AcOEt (8:2) as an eluent.
(Chiralpak AD-H, 3% i-PrOH in hexane, 1.0 mL/min,
tR¼7.9 mindmajor, tR¼12.5 mindminor).
l¼206 nm,
4.2.7.2. (2S,5R)-5-Allyl-5-hydroxy-2-(trityloxymethyl)-tetrahy-
dropyran-4-one (cis-7a). Isomer with lower Rf value in 7:3 hexane/
20
AcOEt compared to trans-7a; [
a]
þ14.1 (c 1.24, CHCl3); IR (film)
D
3549, 2925, 2877, 1721, 1491, 1449, 1223, 1150, 1078, 999, 925 cmꢀ1
;
1H NMR (500 MHz, CDCl3)
d
7.50e7.43 (m, 5H), 7.38e7.11 (m, 10H),
5.78e5.66 (m, 1H), 5.22e5.09 (m, 2H), 4.09 (d, J¼11.2 Hz, 1H), 3.83
(s, 1H), 3.80e3.72 (m, 1H), 3.32 (dd, J¼10.6, 3.6 Hz, 2H), 3.22 (dd,
J¼9.9, 4.5 Hz, 1H), 2.88e2.70 (m, 2H), 2.58 (dd, J¼14.3, 6.6 Hz, 1H),
The product trans-8a was isolated as a white solid with yield in the
20
2.47 (dd, J¼14.1, 2.6 Hz, 1H); 13C NMR (126 MHz, CDCl3)
d
209.6 (C),
range of 62e85%. (2S,5S)-8a: [
a]
ꢀ20.2 (c 1.2, CHCl3); IR (film)
D
143.7 (C), 131.0 (CH), 128.6 (CH), 127.9 (CH), 127.2 (CH), 119.2 (CH2),
86.7 (C), 78.7 (CH), 78.1 (C), 75.4 (CH2), 65.6 (CH2), 42.1 (CH2), 41.1
(CH2); HRMS calcd for C28H28O4Na [(MþNa)þ]: 451.1880; found:
451.1899; HPLC: 98.0% ee (Chiralpak AD-H, 3% i-PrOH in hexane,
3458, 3058, 2872, 1724, 1679, 1490, 1449, 1359, 1215, 1153, 1125,
1078, 747, 705 cmꢀ1; 1H NMR (600 MHz, CDCl3)
d
7.45e7.35 (m, 6H),
7.33e7.26 (m, 6H), 7.26e7.20 (m, 3H), 4.19 (s,1H), 4.01 (d, J¼11.2 Hz,
1H), 3.79e3.70 (m, 1H), 3.37 (d, J¼16.7 Hz, 1H), 3.27 (dd, J¼9.9,
4.3 Hz,1H), 3.24e3.16 (m, 2H), 3.12 (d, J¼16.7 Hz,1H), 2.91e2.78 (m,
J¼13.3, 11.6 Hz, 1H), 2.58 (dd, J¼13.4, 2.8 Hz, 1H), 2.19 (s, 3H); 13C
1.0 mL/min,
l¼206 nm, tR¼21.6 mindmajor, tR¼24.3 mindminor).
4.2.8. Rubottom oxidation of 6b. To a suspension of silyl enol ether
6b (370 mg, 0.952 mmol) and solid NaHCO3 (160 mg, 1.90 mmol) in
AcOEt (10 mL) at 0 ꢁC was added dropwise a pre-cooled (0 ꢁC)
solution of m-CPBA (356 mg, 1.24 mmol, 60% of purity) in AcOEt
(10 mL). After stirring for 1 h at 0 ꢁC, the excess of m-CPBA was
decomposed by addition of a saturated aqueous solution of Na2SO3
(1 mL). The reaction mixture was washed with an aqueous solution
of NaHCO3 (5%, 20 mL) and extracted with AcOEt (3ꢂ10 mL). The
combined organic phases were dried over Na2SO4, filtered, and
concentrated in vacuo. The residue was dissolved in THF (10 mL),
cooled to 0 ꢁC and solution of pre-cooled (0 ꢁC) Bu4NF$3H2O
(0.450 g, 1.43 mmol) in THF (10 mL) was added. After stirring for
15 min, an aqueous solution of NaHCO3 (5%, 20 mL) was added and
product was extracted with AcOEt (3ꢂ15 mL). Combined organic
phases were dried over Na2SO4, filtered, concentrated in vacuo, and
subjected to column chromatography using hexane/AcOEt (9:1) as
an eluent. Purification afforded w1:1 mixture of isomers trans/cis-
7b with 90% yield after two steps (128 mg of the first-eluted trans-
7b and 122 mg of second-eluted cis-7b).
NMR (151 MHz, CDCl3) d 207.9 (C), 206.3 (C), 143.6 (C), 128.6 (CH),
127.9 (CH), 127.2 (CH), 86.8 (C), 79.6 (CH), 76.4 (CH2), 65.6 (CH2),
50.1 (CH2), 42.3 (CH2), 31.3 (CH3); HRMS calcd for C28H28O5Na
[(MþNa)þ]: 467.1829; found: 467.1852; HPLC: 98.0% ee (Chiralpak
AD-H, 5% i-PrOH in hexane, 1.0 mL/min,
tR¼18.2 mindmajor, tR¼22.2 mindminor).
l¼206 nm,
4.2.9.1. (2S,5R)-5-Hydroxy-5-(2-oxopropyl)-2-(trityloxymethyl)-
tetrahydropyran-4-one (cis-8a). Prepared according to the analo-
gous procedure for trans-8a. The product cis-8a was isolated with
65% yield. IR (film) 3425, 3058, 2925, 1719, 1491, 1448, 1412, 1362,
1221, 1177, 1093, 1076, 765, 706 cmꢀ1 1H NMR (600 MHz, CDCl3)
;
d
7.48e7.42 (m, 6H), 7.34e7.28 (m, 6H), 7.28e7.23 (m, 3H), 4.83 (s,
1H), 4.03 (d, J¼12.0 Hz, 1H), 3.92e3.85 (m, 1H), 3.51 (d, J¼12.0 Hz,
1H), 3.36 (dd, J¼9.8, 5.5 Hz, 1H), 3.20 (dd, J¼9.8, 5.1 Hz, 1H),
3.09e3.00 (m, 1H), 2.90 (d, J¼16.7 Hz, 1H), 2.54e2.39 (m, 2H), 2.30
(s, 3H); 13C NMR (151 MHz, CDCl3)
d 209.5 (C), 206.6 (C), 143.6 (C),
128.6 (CH), 127.9 (CH), 127.1 (CH), 86.8 (C), 78.4 (CH), 77.4 (C), 75.3
(CH2), 65.6 (CH2), 43.5 (CH2), 41.7 (CH2), 31.5 (CH3); HPLC: 98.0% ee
(Chiralpak AD-H, 5% i-PrOH in hexane, 1.0 mL/min,
l
¼206 nm,
4.2.8.1. ((2S,5S)-5-Allyl-5-hydroxy-4-oxo-tetrahydro-2H-pyran-
tR¼25.3 mindminor, tR¼28.5 mindmajor); LRMS calcd for
2-yl)methyl benzoate (trans-7b). [
a
]
D
20 ꢀ87.4 (c 1.14, CHCl3); IR (film)
C
28H28O5Na [(MþNa)þ]: 467.2; found: 467.2.
3497, 2959, 2863, 1721, 1452, 1177, 1148, 1111, 1044, 926 cmꢀ1
;
1H
NMR (500 MHz, CDCl3)
d
8.04e7.95 (m, 2H), 7.55e7.49 (m, 1H),
4.2.9.2. ((2S,5S)-5-Hydroxy-5-(2-oxopropyl)-4-oxo-tetrahydro-
7.45e7.35 (m, 2H), 5.72e5.57 (m, 1H), 5.15e5.01 (m, 2H), 4.47e4.30
(m, 2H), 4.04 (d, J¼11.3 Hz, 1H), 4.00e3.90 (m, 1H), 3.75 (s, 1H), 3.31
(d, J¼11.4 Hz, 1H), 2.77e2.61 (m, 2H), 2.60e2.44 (m, 2H); 13C NMR
2H-pyran-2-yl)methyl benzoate (trans-8b). Prepared according to
the analogous procedure for trans-8a. The product (2S,5S)-8b was
isolated with 57% yield. [
a
]
D
20 ꢀ31.1 (c 0.9, CHCl3) [lit.,3b
[a
]
20 ꢀ31.6 (c
D
(126 MHz, CDCl3)
d
208.4 (C), 166.1 (C), 133.4 (CH), 130.8 (CH), 129.7
1.2, CHCl3)]; IR (film) 3456, 2859, 1722, 1451, 1361, 1274, 1157, 1112,
(CH), 129.5 (C), 128.5 (CH), 119.4 (CH), 77.9 (C), 77.1 (CH), 75.2 (CH2),
65.9 (CH2), 41.6 (CH2), 41.1 (CH2); HRMS calcd for C16H18O5Na
[(MþNa)þ]: 313.1047; found: 313.1054.
1071, 713 cmꢀ1 1H NMR (600 MHz, CDCl3)
; d 8.10e8.00 (m, 2H),
7.61e7.55 (m, 1H), 7.48e7.42 (m, 2H), 4.47 (dd, J¼11.8, 3.8 Hz, 1H),
4.42 (dd, J¼11.8, 5.7 Hz, 1H), 4.20 (s, 1H), 4.03 (d, J¼11.3 Hz, 1H),
4.02e3.97 (m, 1H), 3.33 (d, J¼16.6 Hz, 1H), 3.26 (d, J¼11.3 Hz, 1H),
3.12 (d, J¼16.6 Hz, 1H), 2.88e2.81 (m, 1H), 2.72 (dd, J¼13.3, 2.8 Hz,
4.2.8.2. ((2S,5R)-5-Allyl-5-hydroxy-4-oxo-tetrahydro-2H-pyran-
2-yl)methyl benzoate (cis-7b). Isomer with lower Rf value in 7:3
1H), 2.19 (s, 3H); 13C NMR (151 MHz, CDCl3)
d 206.8 (C), 206.3 (C),